Literature DB >> 28381688

Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis during pregnancy.

Masahiro Ikeda1, Rina Oba, Yumiko Yoshiki, Sumito Shingaki, Tomomi Takei, Kanji Miyazaki, Yu Abe, Nobuhiro Tsukada, Tadao Ishida, Kenshi Suzuki.   

Abstract

An 11-week pregnant, 32-year-old Japanese woman who had recovered from infectious mononucleosis visited our center due to fever, anorexia, and bilateral hypochondrial pain. Blood tests revealed leukopenia, thrombocytopenia and elevated ferritin. She was diagnosed with hemophagocytic lymphohistiocytosis (HLH). A high viral load of the Epstein-Barr virus (EBV) was recognized, indicating EBV-HLH. She was treated with a single dose of dexamethasone to protect the fetus. However, the disease was uncontrollable, necessitating etoposide and cyclosporine administration. Remission was obtained with these medications, and she has remained in remission for the 10 months since completion of chemotherapy. Although the occurrence of EBV-HLH during pregnancy is rare, it is possible that a change in cellular immunity associated with the pregnancy may contribute to EBV-HLH development.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28381688     DOI: 10.11406/rinketsu.58.216

Source DB:  PubMed          Journal:  Rinsho Ketsueki        ISSN: 0485-1439


  3 in total

Review 1.  Haemophagocytic lymphohistiocytosis in pregnancy.

Authors:  Harold Wilson-Morkeh; Charlotte Frise; Taryn Youngstein
Journal:  Obstet Med       Date:  2021-09-26

2.  Chronic active Epstein-Barr virus-associated secondary hemophagocytic lymphohistiocytosis in pregnancy: a case report.

Authors:  Masaya Takahashi; Shintaro Makino; Hiroko Iizuka; Masaaki Noguchi; Koyo Yoshida
Journal:  BMC Pregnancy Childbirth       Date:  2021-10-07       Impact factor: 3.007

3.  Pregnancy-associated hemophagocytic lymphohistiocytosis secondary to NK/T cells lymphoma: A case report and literature review.

Authors:  Mengzhou He; Jing Jia; Jingyi Zhang; Rajluxmee Beejadhursing; Lali Mwamaka Sharifu; Jun Yu; Shaoshuai Wang; Ling Feng
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.